Clinical Trial

The Optimal Long Term Treatment Strategy of Anti-resorptive Medications

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is to investigate whether the alternating use of Prolia (Denosumab) and Aclasta (Zoledronic acid) can continue to increase bone density.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-10-22.
Status change: Recruiting → Active, Not Recruiting 2025-05-20
Trial Details
NCT Number NCT05091086
Lead Sponsor National Taiwan University Hospital
Conditions Osteoporosis, Bone Mineral Density
Enrollment 60 participants
Start Date 2021-11-20
Primary Completion 2025-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-22